Home › NDC Lookup › RxCUI directory › RxCUI 1542994

Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream [Neo-Synalar] — RxCUI 1542994

Name: Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream [Neo-Synal… (RxCUI 1542994)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1542994 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1542994

Official nameFluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream [Neo-Synalar]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asNEO-SYNALAR (neomycin sulfate 0.5 % (0.35 % neomycin base) / fluocinolone acetonide 0.025 % ) Topical Cream; NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)1,908 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluocinolone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

The fluocinolone acetonide oil covered here treats atopic dermatitis (eczema) in adults. It is also used for moderate to severe eczema in children 3 months and older, for up to 4 w...
Use a thin film on the affected skin only, and just enough to cover it. Adults use it about three times a day. For children, moisten the skin first and apply about twice a day. Kee...
Not unless your doctor directs it. Avoid the face, underarms, groin and skin folds. Never use it in the diaper area, because diapers can increase how much is absorbed.
Can I put it on my face or my baby's diaper area?

📖 Read our full Fluocinolone Topical guide →

🕸️ Concept Web — How Fluocinolone acetonide 0.25 MG/ML / neomycin sul... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream [Neo-Synalar] RxCUI 1542994 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Fluocinolone 25126 IN
- Neomycin 7299 IN
- Fluocinolone / neomycin 687351 MIN
- Fluocinolone acetonide 4461 PIN
- Neomycin sulfate 7300 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Neo-Synalar 1542990 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Fluocinolone / neomycin Topical Cream 379383 SCDF
- Fluocinolone acetonide / neomycin sulfate Topical Cream 2649255 SCDFP
- Fluocinolone / neomycin Topical Product 1165636 SCDG
- Fluocinolone acetonide / neomycin sulfate Topical Product 2662161 SCDGP
- Fluocinolone / neomycin Topical Cream [Neo-Synalar] 1542992 SBDF
- Fluocinolone acetonide / neomycin sulfate Topical Cream [Neo-Synalar] 2659024 SBDFP
- Neo-Synalar Topical Product 1542993 SBDG
- Topical Cream 316982 DF
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream 1191359 SCD
- Fluocinolone acetonide 0.25 MG/ML 1191314 SCDC
- Neomycin sulfate 5 MG/ML 1191358 SCDC
- Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML [Neo-Synalar] 1542991 SBDC

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream SCD · 1191359
Fluocinolone acetonide 0.25 MG/ML SCDC · 1191314
Neomycin sulfate 5 MG/ML SCDC · 1191358
Fluocinolone / neomycin Topical Cream SCDF · 379383
Fluocinolone acetonide / neomycin sulfate Topical Cream SCDFP · 2649255
Fluocinolone / neomycin Topical Product SCDG · 1165636
Fluocinolone acetonide / neomycin sulfate Topical Product SCDGP · 2662161

Brand-Name Concepts

Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML [Neo-Synalar] SBDC · 1542991
Fluocinolone / neomycin Topical Cream [Neo-Synalar] SBDF · 1542992
Fluocinolone acetonide / neomycin sulfate Topical Cream [Neo-Synalar] SBDFP · 2659024
Neo-Synalar Topical Product SBDG · 1542993
Neo-Synalar BN · 1542990

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1542994 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
43538-0940-60	1 TUBE in 1 CARTON (43538-940-60) / 60 g in 1 TUBE	Neo-Synalar	Eurofarma, Inc.	1963-06-11
43538-0940-99	4 TUBE in 1 CARTON (43538-940-99) / 3 g in 1 TUBE	Neo-Synalar	Eurofarma, Inc.	1963-06-11

Observed labelers: Eurofarma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.